Merck CEO Rob Davis joins Bloomberg's Jonathan Ferro and Lisa Abramowicz to discuss the approval of the company's treatment for high blood pressure called Winrevair.

US Interior Secretary Doug Burgum Talks US Energy Production
14:53

Nobel Laureate & CUNY Economics Professor Paul Krugman Talks Powell Investigation
06:04

Burlington CEO Michael O'Sullivan Talks Growth, Consumer Sentiment
10:04